NetworkNewsBreaks – Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) Featured in Mizuho Securities Research Report
Xeris Pharmaceuticals (NASDAQ: XERS) was featured in a recent U.S. Equity Research Report published by Mizuho Securities USA LLC. The report reads, “We are including IQVIA scripts for Gvoke and glucagon below for the week ended 1/31/2020. Please note that these numbers were affected by the holiday on 1/20/2020 as expected. Gvoke TRx was +8.0% to 230 from 213 the prior week; Gvoke NRx was +7.2% to 222 from 207 the prior week. Total Glucagon TRx was 12,771, +16.2% y/y; total Glucagon NRx was +17.7% y/y to 10,245.” To request access to the full report, visit http://nnw.fm/SaZ9d About Xeris Pharmaceuticals,…







